The Board of Directors of Diplomat Pharmacy, Inc. sets high standards for the company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the company's business.

Complaints or concerns related to Diplomat accounting, auditing, internal controls or financial reporting can be submitted anonymously and confidentially. For Diplomat employees or external parties wishing to access the Ethics Line, please refer to instructions in the “Ethics Line FAQ” document located below.

NYSE: DPLO

+0.07 +0.35% $ 20.24 Volume: 637,684 Common Stock | 20 minute delay October 19, 2018

Investor Contact

Terri Anne Powers,
Vice President, Investor Relations
Diplomat Pharmacy Inc.
tpowers@diplomat.is
Phone: 312.889.5244

Email Now